SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-19-102832
Filing Date
2019-04-10
Accepted
2019-04-10 16:23:02
Documents
52
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d656298d10k.htm 10-K 729868
2 EX-23.1 d656298dex231.htm EX-23.1 4635
3 EX-31.1 d656298dex311.htm EX-31.1 9392
4 EX-31.2 d656298dex312.htm EX-31.2 9206
5 EX-32.1 d656298dex321.htm EX-32.1 4484
  Complete submission text file 0001193125-19-102832.txt   4295170

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT matn-20181231.xml EX-101.INS 1201040
7 XBRL TAXONOMY EXTENSION SCHEMA matn-20181231.xsd EX-101.SCH 29933
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE matn-20181231_cal.xml EX-101.CAL 26753
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE matn-20181231_def.xml EX-101.DEF 60837
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE matn-20181231_lab.xml EX-101.LAB 250684
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE matn-20181231_pre.xml EX-101.PRE 173687
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21990 | Film No.: 19741905
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1